The overall expression and enzymatic activity of CTSB in GBM could be regulated through the alternative splicing of the pre-mRNA of CTSB39,40, which determined by the differentiation and microenvironment of tumor cells and in return influence the malignant behavior of GBM39. The gene discussed is CTSB; the disease is glioblastoma.